Not only were ROS levels in SKVO3 ovarian cancer cells increased, but the expression of XIAP (X-linked inhibitor of apoptosis), cyclin D1, and BCL2 genes was reduced upon treatment with the triple combination, leading to increased cytotoxicity of SKOV-3 cells [103]. This evidence concerns the gene XIAP and ovarian carcinoma.